Yuval Cohen has sold CRBP and made no open-market buys since Jun 2024
Chief Executive Officer at Corbus Pharmaceuticals Holdings, Inc.
SEC CIK 0001626003 · Filings on SEC.gov ↗
$0Bought
$3.2MSold
NoneLast buy
Every filing
3 filings since Jun 2024, newest first
Filings come from SEC EDGAR. Not investment advice.